During mitosis, TCF3 dissociates from ASCL1, leading to its degradation, while chemotherapy significantly reduces ASCL1 transcription, enhancing SCLC cell sensitivity to treatment [53]. This evidence concerns the gene ASCL1 and small cell lung carcinoma.